Venous thromboembolism: a UK perspective.
Venous thromboembolism remains a significant cause of morbidity and mortality in the UK, and its dangers, particularly in hospitalized patients, have long been recognized. Recent measures to tackle this problem and new treatments should alleviate the burden of venous thromboembolism for patients, their families and hospital services.
Kakkar
Ajay
A
Barts and the London School of Medicine and Dentistry Hospital, London, UK.
D000925:Anticoagulants / Q000627:therapeutic use*; D005170:Factor X / Q000037:antagonists & inhibitors; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013917:Thrombin / Q000037:antagonists & inhibitors; D006113:United Kingdom; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D005170:Factor X; D013917:Thrombin